Cargando…

Smad7 protects against chronic aristolochic acid nephropathy in mice

Chronic Aristolochic Acid Nephropathy (AAN) is a progressive chronic kidney disease related to herb medicine. However, treatment for chronic AAN remains ineffective. We report here that Smad7 is protective and has therapeutic potential for chronic AAN. In a mouse model of chronic AAN, progressive re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Xiao-Yu, Zhou, Li, Huang, Xiao-Ru, Fu, Ping, Lan, Hui-Yao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Pathology: Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494914/ https://www.ncbi.nlm.nih.gov/pubmed/25883225

Ejemplares similares

Targeting c-fms kinase attenuates chronic aristolochic acid nephropathy in mice
por: Dai, Xiao Y., et al.
Publicado: (2016)

Protective Effects of Melatonin Against Aristolochic Acid-Induced Nephropathy in Mice
por: Kim, Jung-Yeon, et al.
Publicado: (2019)

Renal Protective Effects of 17β-Estradiol on Mice with Acute Aristolochic Acid Nephropathy
por: Shi, Min, et al.
Publicado: (2016)

Renal angiotensin I-converting enzyme-deficient mice are protected against aristolochic acid nephropathy
por: Juretzko, Annett, et al.
Publicado: (2022)

Rapamycin protects against aristolochic acid nephropathy in mice by potentiating mammalian target of rapamycin-mediated autophagy
por: Lin, Fan, et al.
Publicado: (2021)

Update of aristolochic acid nephropathy in Korea
por: Ban, Tae Hyun, et al.
Publicado: (2018)

Overview of aristolochic acid nephropathy: an update
por: Zhou, Qingqing, et al.
Publicado: (2023)

Treatment of renal fibrosis by rebalancing TGF-β/Smad signaling with the combination of asiatic acid and naringenin
por: Meng, Xiao-ming, et al.
Publicado: (2015)

Deletion of Smad3 improves cardiac allograft rejection in mice
por: Wang, Ying-ying, et al.
Publicado: (2015)

An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature
por: Jadot, Inès, et al.
Publicado: (2017)

Effects of aristolochic acid I and/or hypokalemia on tubular damage in C57BL/6 rat with aristolochic acid nephropathy
por: Yi, Joo-Hark, et al.
Publicado: (2018)

Arterial Stiffness in Balkan Endemic Nephropathy, an Environmental Form of Aristolochic Acid Nephropathy
por: Premužić, Vedran, et al.
Publicado: (2018)

Deletion of Smad3 protects against C-reactive protein-induced renal fibrosis and inflammation in obstructive nephropathy
por: You, Yong-Ke, et al.
Publicado: (2021)

«Suspects» in Etiology of Endemic Nephropathy: Aristolochic Acid versus Mycotoxins
por: Pepeljnjak, Stjepan, et al.
Publicado: (2010)

Pharmacokinetics of p-Aminohippuric Acid and Inulin in Rabbits with Aristolochic Acid Nephropathy
por: Tseng, Chiao-Shih, et al.
Publicado: (2011)

Integrative microRNA and mRNA expression profiling in acute aristolochic acid nephropathy in mice
por: Zhu, Ziqiang, et al.
Publicado: (2020)

Aristolochic Acid Induces Chronic Kidney Disease in ACE Knockout Mice
por: Wu, Jia-Ping
Publicado: (2021)

Growing risk of aristolochic acid nephropathy in the era of COVID-19 – Correspondence
por: Das, Tuyelee, et al.
Publicado: (2022)

Deletion of Smad3 protects against diabetic myocardiopathy in db/db mice
por: Dong, Li, et al.
Publicado: (2021)

Blockade of the mTOR signaling pathway with rapamycin ameliorates aristolochic acid nephropathy
por: Wu, Minmin, et al.
Publicado: (2020)

Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy
por: Ishii, Takeo, et al.
Publicado: (2021)

Protective Effect of Nebivolol against Oxidative Stress Induced by Aristolochic Acids in Endothelial Cells
por: Antoine, Marie-Hélène, et al.
Publicado: (2022)

Aristolochic Acid Induces Renal Fibrosis and Senescence in Mice
por: Urate, Shingo, et al.
Publicado: (2021)

Aristolochic acid nephropathy: A scientometric analysis of literature published from 1971 to 2019
por: Ji, Hongjian, et al.
Publicado: (2021)

Experimental Aristolochic Acid Nephropathy: A Relevant Model to Study AKI-to-CKD Transition
por: Baudoux, Thomas, et al.
Publicado: (2022)

Progress in Pathogenesis of Immunoglobin A Nephropathy
por: Stanley, Jemima C, et al.
Publicado: (2020)

Dahuang Fuzi Decoction Attenuates Renal Fibrosis and Ameliorates Mitochondrial Dysfunction in Chronic Aristolochic Acid Nephropathy
por: Shui, Guang-xing, et al.
Publicado: (2017)

Balkan Endemic Nephropathy: An Autopsy Case Report
por: Stoyanov, George S, et al.
Publicado: (2021)

Immunoglobulin M Nephropathy in a Patient with Wilson’s Disease
por: Ul Abideen, Zain, et al.
Publicado: (2016)

Bioinformatics facilitating the use of microarrays to delineate potential miRNA biomarkers in aristolochic acid nephropathy
por: Lv, Yana, et al.
Publicado: (2016)

Mesenchymal Stem Cell Derived Extracellular Vesicles Ameliorate Kidney Injury in Aristolochic Acid Nephropathy
por: Kholia, Sharad, et al.
Publicado: (2020)

Lycopene attenuates the inflammation and apoptosis in aristolochic acid nephropathy by targeting the Nrf2 antioxidant system
por: Wang, Yu, et al.
Publicado: (2022)

Assessment of nephrotoxicity of herbal medicine containing aristolochic acid in mice
por: Quan, Yi, et al.
Publicado: (2020)

The Presence of Testis Determines Aristolochic Acid-Induced Nephrotoxicity in Mice
por: Li, Wei-Long, et al.
Publicado: (2023)

Aristolochic Acid-Induced Genotoxicity and Toxicogenomic Changes in Rodents
por: Li, Xi-Lin, et al.
Publicado: (2020)

Aristolochic Acid-Induced Nephrotoxicity: Molecular Mechanisms and Potential Protective Approaches
por: Anger, Etienne Empweb, et al.
Publicado: (2020)

Protective effect of hydrogen sulphide against myocardial hypertrophy in mice
por: Shao, Mingjing, et al.
Publicado: (2017)

Ultrasound enhances the therapeutic potential of mesenchymal stem cells wrapped in greater omentum for aristolochic acid nephropathy
por: Yang, Yuanjun, et al.
Publicado: (2021)

Restored nitric oxide bioavailability reduces the severity of acute-to-chronic transition in a mouse model of aristolochic acid nephropathy
por: Jadot, Inès, et al.
Publicado: (2017)

AANG Prevents Smad3-dependent Diabetic Nephropathy by Restoring Pancreatic β-Cell Development in db/db Mice
por: Chung, Jeff Yat-Fai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vp249f7aq0lld5i77tqtnmcjh7